Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | January 2021

In the ordinary rebalance the following composition will be implemented effective open 08.01.2021:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
AMGEN INC
BAXTER INTL.
BECTON DICKINSON AND CO
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
BRUKER CORP
CHEMED CORP
CHINA BIOLOGIC PRODUCTS HOLD
CHR HANSEN HOLDING AS
COLOPLAST AS CLASS B
COOPER COMPANIES INC
DANAHER CORP
DAVITA INC
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
GILEAD SCIENCES INC
HUMANA INC
ICU MEDICAL INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LABORATORY CRP OF AMER HLDGS
LHC GROUP INC
LONZA GROUP AG
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
METTLER-TOLEDO INTL
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES AS CLASS B
PFIZER INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
STERIS PLC
STRAUMANN HOLDING AG
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITEDHEALTH GROUP INC
WATERS CORP
WEST PHARMACEUTICAL SERVICES INC
ZOETIS INC